In this valuable study, Roiuk et al employed a combination of ribosome profiling and reporter assays to provide convincing evidence that eIF2A is not involved in translational regulation in cultured ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population ...

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Ramesh and Rajeev Juneja of Mankind Pharma fought popular perceptions and made large acquisitions, focussed on specialty ...

Adam Townsend, chief operating officer, has decided to pursue a new opportunity as a chief executive officer at a private biotechnology company and will depart Apellis on February 21, 2025. Since ...

Inhibition of protein phosphatase 1 by other drugs or siRNA also increased cell-surface calreticulin. Both of these approaches, as well as recombinant calreticulin, could divert tumor cells from a ...

Engineers escorted a 209,000-pound cooler into its new home at Fermilab in Batavia, as part of a new particle accelerator ...

Attosecond science allows the extremely fast movements of electron particles to be observed. This emerging field brings both ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...

The US biotech has just reported phase 2 trial results with the small, interfering RNA (siRNA) gene-silencing drug showing that it an cause a 90% or greater reduction in Lp(a) levels – a risk ...

In a study published in PNAS, Dr. CHAO Yanjie at the Shanghai Institute of Immunity and Infection of the Chinese Academy of Sciences and Dr. WANG Chuan from Fudan University revealed how a ...